Home LiteratureArticle Details
PMID: 2228245 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS.

Infection and immunity ·Vol. 58 ·No. 11 ·1990-11-00 ·Pages 3743-50

Loppnow H, Libby P, Freudenberg M, Krauss JH, Weckesser J, Mayer H

Abstract

Many pathological effects of gram-negative bacteria are produced by their cell wall-derived lipopolysaccharides (LPSs). Differing pathogenicity of gram-negative LPSs, however, may depend on their capacities to induce cytokines. Thus, we studied the lethal toxicity of four nonenterobacterial LPSs and compared it with their capacity to induce mononuclear cell (MNC)-derived interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF). Unstimulated MNC did not release these cytokines. LPS from the phototrophic strain Rhodobacter capsulatus 37b4 elaborated little toxicity in galactosamine-treated mice (10 micrograms of LPS per mouse was the 100% lethal dose [LD100]) and induced IL-1 and IL-6 release only at high concentrations (10 to 50 micrograms of LPS per ml). R. capsulatus LPS failed to induce TNF activity even at the highest concentration tested (100 micrograms of LPS per ml). In contrast, LPS derived from Pseudomonas diminuta NCTC 8545 or the nodulating species Bradyrhizobium lupini DSM 30140 and Rhizobium meliloti 10406 expressed lethal toxicity (LD100, 1,000, 100, and 10 ng per mouse, respectively) and induced IL-1 or IL-6 (10 to 100, 10, and 1 ng of LPS per ml, respectively) at concentrations 1,000- to 10,000-fold lower than effective levels of R. capsulatus LPS. LPSs from P. diminuta, B. lupini, and R. meliloti also stimulated TNF production and release. MNC accumulated cell-associated IL-1 activities under circumstances in which released activity was readily detected. The cells contained only scant IL-6 activity, indicating release of this mediator rather than intracellular accumulation. Antisera to the respective cytokines inactivated biological activities of the samples selectively. The R. capsulatus LPS inhibited cytokine induction by LPS from P. diminuta, B. lupini, and R. meliloti in coincubation experiments. These results show that the in vivo lethality of the LPSs tested correlates with the induction of monocyte-derived cytokines in vitro. The results of this study suggest that the different lethality of various LPSs from gram-negative bacteria may be due to the differential ability of these LPSs to induce cytokine production.

MeSH Terms
Animals Cytokines/biosynthesis Leukocytes, Mononuclear/drug effects,metabolism Lipopolysaccharides/chemistry,toxicity Mice Mice, Inbred C57BL Mortality Rhodobacter capsulatus/analysis Structure-Activity Relationship
Chemicals
Cytokines Lipopolysaccharides
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Loppnow H
Tufts University School of Medicine, Boston, Massachusetts.
Libby P
Freudenberg M
Krauss J H
Weckesser J
Mayer H
References (50)
50 references, click to expand
  1. Purification and physico-chemical characterization of rabbit tumor necrosis factor.
    J Immunol. 1980 Oct;125(4):1671-7 PMID: 6997383
  2. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  3. Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils.
    Fed Proc. 1987 Jan;46(1):97-104 PMID: 3542580
  4. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.
    Lab Invest. 1987 Mar;56(3):234-48 PMID: 3029503
  5. Pseudomonas diminuta LPS with a new endotoxic lipid A structure.
    Biochem Biophys Res Commun. 1987 Feb 13;142(3):972-8 PMID: 3827908
  6. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.
    Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251-5 PMID: 2444978
  7. Production of hybridoma growth factor by human monocytes.
    Eur J Immunol. 1987 Oct;17(10):1411-6 PMID: 3500054
  8. T cell growth factor: parameters of production and a quantitative microassay for activity.
    J Immunol. 1978 Jun;120(6):2027-32 PMID: 307029
  9. Galactosamine-induced sensitization to the lethal effects of endotoxin.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5939-43 PMID: 293694
  10. Endogenous pyrogens made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages.
    J Immunol. 1980 May;124(5):2498-501 PMID: 6965973
  11. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
    J Clin Invest. 1988 Apr;81(4):1162-72 PMID: 3258319
  12. Enhanced production of monokines by canine alveolar macrophages in response to endotoxin-induced shock.
    Proc Soc Exp Biol Med. 1988 Apr;187(4):408-15 PMID: 3281166
  13. Detection of circulating tumor necrosis factor after endotoxin administration.
    N Engl J Med. 1988 Jun 9;318(23):1481-6 PMID: 2835680
  14. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
    J Clin Invest. 1988 Jun;81(6):1925-37 PMID: 3384955
  15. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha.
    Eur J Immunol. 1988 Aug;18(8):1259-64 PMID: 3138137
  16. Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.
    Infect Immun. 1988 Oct;56(10):2650-7 PMID: 3262089
  17. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages.
    Blood. 1988 Oct;72(4):1134-40 PMID: 3262381
  18. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
    J Immunol. 1988 Nov 1;141(9):3050-4 PMID: 3262676
  19. Monophosphoryl lipid A blocks the hemodynamic effects of lethal endotoxemia.
    J Lab Clin Med. 1989 Jan;113(1):112-7 PMID: 2909645
  20. Somnogenic activities of synthetic lipid A.
    Infect Immun. 1989 Feb;57(2):396-403 PMID: 2912895
  21. Interleukin-1 and its biologically related cytokines.
    Adv Immunol. 1989;44:153-205 PMID: 2466396
  22. Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide.
    Infect Immun. 1989 Apr;57(4):1336-8 PMID: 2784418
  23. Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice.
    Infect Immun. 1989 May;57(5):1483-90 PMID: 2707856
  24. IL-1 induction-capacity of defined lipopolysaccharide partial structures.
    J Immunol. 1989 May 1;142(9):3229-38 PMID: 2651523
  25. Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages.
    J Infect Dis. 1989 May;159(5):872-80 PMID: 2651532
  26. Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4.
    Eur J Biochem. 1989 Apr 1;180(3):519-26 PMID: 2714269
  27. 27-Hydroxyoctacosanoic acid is a major structural fatty acyl component of the lipopolysaccharide of Rhizobium trifolii ANU 843.
    J Biol Chem. 1989 Jun 5;264(16):9300-3 PMID: 2722834
  28. Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1.
    Cell Immunol. 1989 Sep;122(2):493-503 PMID: 2788520
  29. Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells.
    Lymphokine Res. 1989 Fall;8(3):293-9 PMID: 2789322
  30. Detection of interleukin 1 with human dermal fibroblasts.
    Immunobiology. 1989 Jun;179(2-3):283-91 PMID: 2477329
  31. Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.
    J Exp Med. 1990 Mar 1;171(3):889-96 PMID: 2307935
  32. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.
    J Clin Invest. 1990 Mar;85(3):731-8 PMID: 2312724
  33. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.
    J Exp Med. 1990 Jul 1;172(1):77-84 PMID: 2193101
  34. Characterization of a subclone (D10S) of the D10.G4.1 helper T-cell line which proliferates to attomolar concentrations of interleukin-1 in the absence of mitogens.
    Cytokine. 1989 Nov;1(1):14-22 PMID: 2535250
  35. Interleukin 1, a potential regulator of fibroblast proliferation.
    J Immunol. 1982 May;128(5):2177-82 PMID: 6460819
  36. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
    Anal Biochem. 1982 Jan 1;119(1):115-9 PMID: 6176137
  37. Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023.
    J Bacteriol. 1983 Jul;155(1):153-8 PMID: 6602801
  38. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.
    J Immunol Methods. 1984 Mar 30;68(1-2):167-75 PMID: 6707477
  39. Increased plasma interleukin-1 activity in women after ovulation.
    Science. 1985 Mar 8;227(4691):1247-9 PMID: 3871966
  40. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities.
    Eur J Biochem. 1985 Apr 1;148(1):1-5 PMID: 2579812
  41. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Science. 1985 Aug 30;229(4716):869-71 PMID: 3895437
  42. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.
    J Exp Med. 1985 Sep 1;162(3):930-42 PMID: 2411843
  43. Tumor necrosis factor (TNF).
    Science. 1985 Nov 8;230(4726):630-2 PMID: 2413547
  44. Interleukin 1: an immunological perspective.
    Annu Rev Immunol. 1985;3:263-87 PMID: 2933048
  45. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin.
    Infect Immun. 1986 Mar;51(3):891-5 PMID: 3949385
  46. Differences between intra- and extracellular interleukin-1.
    Mol Immunol. 1985 Dec;22(12):1387-92 PMID: 3879529
  47. Cachectin and tumour necrosis factor as two sides of the same biological coin.
    Nature. 1986 Apr 17-23;320(6063):584-8 PMID: 3010124
  48. Structure-activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A's with different fatty acid compositions.
    J Biochem. 1986 Apr;99(4):1203-10 PMID: 2423510
  49. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
    J Exp Med. 1986 Jun 1;163(6):1433-50 PMID: 3486936
  50. Induction of human interleukin 1 by bacterial and synthetic lipid A.
    Eur J Immunol. 1986 Oct;16(10):1263-7 PMID: 3490388
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1990-11-00
Pages
3743-50
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC313723
Subset
IM
Grants
NHLBI NIH HHS · HL 34636 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]